Failure to consider the complex and diverse markets you wish to enter can lead to an irrelevant product position resulting in challenges with reimbursement. Your winning position depends on early identification of key asset attributes that are clinically relevant.

Leveraging local KOL networks will help you to better understand where your winning position will be, providing you with crucial data that will inform your clinical development, access, and commercial strategy. EVA WAY^® commercial and market access experts provide guidance and work closely with market research agencies to ensure you get the most out of the research you conduct. 

As you develop your plans we are also there to act as your sounding board. Together we will fine-tune your ex-US commercial strategy and provide de-risking options. 

Draw upon our ex-US marketing & launch expertise and ensure you have all the data to make your best decisions.